Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronghua Luo

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
European Journal of Medicinal Chemistry|July 10, 2021
Lead optimization to improve the antiviral potency of 2-aminobenzamide derivatives targeting HIV-1 Vif-A3G axisXinxin Zhong, Ronghua Luo, Guoyi Yan, et al.
Orphanet Journal of Rare Diseases|April 8, 2018
A pilot screening of high-risk Gaucher disease children using dried blood spot methods in Shandong province of ChinaKe Lei, Yanxia Zhao, Lirong Sun, et al.
Journal of Thoracic Disease|May 1, 2018
Peak expiratory flow among healthy children aged 5-14 years in ChinaYanhong Lu, Jinping Zheng, Chuanhe Liu, et al.
Cell Death & Disease|December 9, 2020
A cross-talk between epithelium and endothelium mediates human alveolar-capillary injury during SARS-CoV-2 infectionPeng Wang, Ronghua Luo, Min Zhang, et al.
Viruses|November 11, 2022
Structure-Based Discovery and Characterization of a Preclinical Drug Candidate for the Treatment of HIV-1 InfectionDongwei Kang, Jinxuan Yang, Lingjin Kong, et al.
Science Bulletin|July 19, 2021
Corrigendum to "SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chip" [Sci. Bull. (2021) 66 (8) 783-793]Yaqiong Guo, Ronghua Luo, Yaqing Wang, et al.
Science Bulletin|December 7, 2020
SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chipYaqiong Guo, Ronghua Luo, Yaqing Wang, et al.
Chinese Journal of Natural Medicines|April 24, 2024
Seco-cyclic phorbol derivatives and their anti-HIV-1 activitiesXiaolei Huang, Xusheng Huang, Qirun Li, et al.
Acta Pharmaceutica Sinica. B|March 7, 2020
Synthesis and biological evaluation of a series of 2-(((5-akly/aryl-1<i>H</i>-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3<i>H</i>)-ones as potential HIV-1 inhibitorsYumeng Wu, Chengrun Tang, Ruomei Rui, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2024
Discovery of L15 as a novel Vif PROTAC degrader with antiviral activity against HIV-1Dan Luo, Ronghua Luo, Weilin Wang, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
European Journal of Medicinal Chemistry|July 10, 2021
Lead optimization to improve the antiviral potency of 2-aminobenzamide derivatives targeting HIV-1 Vif-A3G axisXinxin Zhong, Ronghua Luo, Guoyi Yan, et al.
Orphanet Journal of Rare Diseases|April 8, 2018
A pilot screening of high-risk Gaucher disease children using dried blood spot methods in Shandong province of ChinaKe Lei, Yanxia Zhao, Lirong Sun, et al.
Journal of Thoracic Disease|May 1, 2018
Peak expiratory flow among healthy children aged 5-14 years in ChinaYanhong Lu, Jinping Zheng, Chuanhe Liu, et al.
Cell Death & Disease|December 9, 2020
A cross-talk between epithelium and endothelium mediates human alveolar-capillary injury during SARS-CoV-2 infectionPeng Wang, Ronghua Luo, Min Zhang, et al.
Viruses|November 11, 2022
Structure-Based Discovery and Characterization of a Preclinical Drug Candidate for the Treatment of HIV-1 InfectionDongwei Kang, Jinxuan Yang, Lingjin Kong, et al.
Science Bulletin|July 19, 2021
Corrigendum to "SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chip" [Sci. Bull. (2021) 66 (8) 783-793]Yaqiong Guo, Ronghua Luo, Yaqing Wang, et al.
Science Bulletin|December 7, 2020
SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chipYaqiong Guo, Ronghua Luo, Yaqing Wang, et al.
Chinese Journal of Natural Medicines|April 24, 2024
Seco-cyclic phorbol derivatives and their anti-HIV-1 activitiesXiaolei Huang, Xusheng Huang, Qirun Li, et al.
Acta Pharmaceutica Sinica. B|March 7, 2020
Synthesis and biological evaluation of a series of 2-(((5-akly/aryl-1<i>H</i>-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3<i>H</i>)-ones as potential HIV-1 inhibitorsYumeng Wu, Chengrun Tang, Ruomei Rui, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2024
Discovery of L15 as a novel Vif PROTAC degrader with antiviral activity against HIV-1Dan Luo, Ronghua Luo, Weilin Wang, et al.
Pageof 4